Zobrazeno 1 - 10
of 444
pro vyhledávání: '"D, Caille"'
Autor:
Zi, Shuang‐Feng1 (AUTHOR), Wu, Xiao‐Jing1 (AUTHOR), Tang, Ying1 (AUTHOR), Liang, Yun‐Peng1 (AUTHOR), Liu, Xu1 (AUTHOR), Wang, Lu1 (AUTHOR), Li, Song‐Li1 (AUTHOR), Wu, Chang‐De1 (AUTHOR), Xu, Jing‐Yuan1 (AUTHOR), Liu, Tao1,2 (AUTHOR), Huang, Wei1 (AUTHOR), Xie, Jian‐Feng1 (AUTHOR), Liu, Ling1 (AUTHOR), Chao, Jie1,3 (AUTHOR) chaojie@seu.edu.cn, Qiu, Hai‐Bo1 (AUTHOR) 101008555@seu.edu.cn
Publikováno v:
Advanced Science. 10/16/2024, Vol. 11 Issue 38, p1-17. 17p.
Autor:
Bernard Scatton, Henri Depoortere, O. Curet, D. Caille, O. Bergis, N. Sontag, P. Avenet, C. Sauvage, G. Damoiseau-Ovens
Publikováno v:
Journal of Affective Disorders. 51:287-303
Befloxatone, a novel oxazolidinone derivative, is a potent, selective and reversible monoamine oxidase A (MAO-A) inhibitor in vitro (K1A = 1.9-3.6 nM) and ex vivo (ED50 MAO-A = 0.02 mg/kg, p.o.). It does not interact with a large number of receptors,
Publikováno v:
Polymer Bulletin. 24:31-38
Reactions between a diepoxide and a diisocyanate can lead to copolymers having isocyanurate and oxazolidone rings in their chemical structure. Using Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FTIR), we have s
Publikováno v:
Polymer Bulletin. 24:23-30
Etude par FTIR et DSC de l'influence du catalyseur (benzyl dimethyl amine) sur le mecanisme de la reaction et du rapport molaire des comonomeres (DGEBA/MDI) sur la Tg des copolymeres reticules oxazolidone/isocyanurate formes
Autor:
N, Aubin, P, Barneoud, C, Carter, D, Caille, N, Sontag, C, Marc, J, Lolivier, A, Gardes, C, Perron, A, Le Kim, T, Charieras, M, Pandini, P, Burnier, F, Puech, S, Jegham, P, George, B, Scatton, O, Curet
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 310(3)
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one] is a new, nonselective, and reversible monoamine oxidase (MAO) inhibitor, belonging to a oxazoloquinolinone series. In vitro studies
Autor:
A, Barbier, D, Caille
Publikováno v:
Therapie. 57(2)
Safety Pharmacology is now specified by various European and international guidelines. The ICHS7A text, which has now been implemented, requires all new compounds to be tested before any administration in humans. The compound should be evaluated unde
Autor:
Saccenti, Daniele1 (AUTHOR) saccenti.phd@milano-sfu.it, Lodi, Leandro1 (AUTHOR) leo.lodi18@yahoo.com, Moro, Andrea Stefano1,2 (AUTHOR) moro.phd@milano-sfu.it, Scaini, Simona1,3 (AUTHOR) b.forresi@milano-sfu.it, Forresi, Barbara1 (AUTHOR) m.ferro@milano-sfu.it, Lamanna, Jacopo2,4 (AUTHOR), Ferro, Mattia1,2 (AUTHOR)
Publikováno v:
Brain Sciences (2076-3425). Mar2024, Vol. 14 Issue 3, p210. 26p.
Autor:
D, Caille, O E, Bergis, C, Fankhauser, A, Gardes, R, Adam, T, Charieras, A, Grosset, V, Rovei, F X, Jarreau
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(1)
The pharmacological profile of befloxatone, a reversible, selective and competitive inhibitor of monoamine oxidase-A has been investigated in rodents. In mice, befloxatone was more active at potentiating generalized tremors induced by L-5-hydroxytryp
Publikováno v:
Journal of neural transmission. Supplementum. 41
In vitro and ex-vivo studies show that befloxatone, a new oxazolidinone derivative, is a potent, reversible, competitive and specific MAO-A inhibitor (KiA from 1.9 to 3.6 nM and KiB/KiA ratio between 100 and 400, in the Rat and in Man, depending on t
Publikováno v:
Amine Oxidases: Function and Dysfunction ISBN: 9783211825211
In vitro and ex-vivo studies show that befloxatone, a new oxazolidinone derivative, is a potent, reversible, competitive and specific MAO-A inhibitor (KiA from 1.9 to 3.6 nM and KiB/KiA ratio between 100 and 400, in the Rat and in Man, depending on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a217261cc2b39f16352d08f81ffc5d0
https://doi.org/10.1007/978-3-7091-9324-2_45
https://doi.org/10.1007/978-3-7091-9324-2_45